Short Course Daratumumab in Patients With Multiple Myeloma

NCT03490344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Daratumumab
DRUG: Lenalidomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]